Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00455507
Recruitment Status : Completed
First Posted : April 3, 2007
Last Update Posted : August 29, 2012
Information provided by (Responsible Party):
Kyowa Kirin Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2008
Actual Study Completion Date : August 2008